Author:
Sakamaki Kentaro,Kamiura Toshifumi,Morita Yusuke,Iba Katsuhiro,Yoshida Seitaro,Wakana Akira,Tsuchiya Satoru,Fukimbara Satoru,Suganami Hideki
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference13 articles.
1. Cook RJ, Farewell VT. Multiplicity considerations in the design and analysis of clinical trials. J R Stat Soc Ser A. 1996;159:93–110.
2. Parmar MK, Carpenter J, Sydes MR. More multi-arm randomised trials of superiority are needed. Lancet. 2014;384:283–284.
3. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline: Statistical principles for clinical trials-E9. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf. Accessed December 28, 2015.
4. Committee for Proprietary Medicinal Products. Points to consider on multiplicity issues in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003640.pdf. Accessed December 28, 2015.
5. Wason JM, Stecher L, Mander AP. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done? Trials. 2014;15:364.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献